Navigation MenuRealWire Limited

Delivering Relevance, Releasing Influence




BALT International Announces First Patient Enrolled in the MARCO POLO Randomized Clinical Trial.

BALT International have announced the enrolment of their first patient in MARCO POLO. The story was covered by biocompare a site dedicated to the latest news on the biotech industry. biocompare is a relevant site for BALT to gain coverage on as it will reach a large amount of biotech industry professionals who may be interested in their patient announcement of MARCO POLO. 



RealWire Influence Rating3 star

BALT International Announces First Patient Enrolled In The MARCO POLO Randomized Clinical Trial.
biocompare claims to be the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information. Produced by scientists, Biocompare's mission is to provide free, time saving services to life science researchers, allowing scientists to find and learn about the technologies that drive discovery.